Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07630155 · ClinicalTrials.gov registry record · NA

Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma

A NA study, sponsored by University of Michigan Rogel Cancer Center.

Recruiting
Registry status
NA
Development phase
10
Enrollment target

NCT07630155 is a NA study that is actively recruiting participants, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07630155, a NA study, is actively recruiting participants, sponsored by University of Michigan Rogel Cancer Center.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

This clinical trial tests how well office based ureteroscopy utilizing a single use digital, flexible ureteroscope works for the assessment of upper tract urothelial carcinoma. Ureteroscopy is a procedure in which a thin camera called a ureteroscope is used to assess patients with a known or suspected diagnosis of upper tract urothelial carcinoma. Ureteroscopy is traditionally performed in an operating room under general anesthesia. In this study, patients undergo ureteroscopy in the doctor's office using an ultra-thin ureteroscope, which is the narrowest instrument of its kind. Because of its small size, researchers believe this procedure can be completed in the office with minimal discomfort and high patient satisfaction, which may eliminate the risks of general anesthesia and reduce delays to diagnosis. Office based ureteroscopy utilizing a single use digital, flexible ureteroscope may be effective for the assessment of upper tract urothelial carcinoma.

Interventions

  • OTHER Survey Administration
  • OTHER Electronic Health Record Review
  • DEVICE Medical Device Usage and Evaluation
  • DRUG Analgesic Agent
  • DRUG Lidocaine Topical

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-08
Est. Completion 2027-08
Phase NA

What the Registry Record Tells You About NCT07630155

The ClinicalTrials.gov registry entry for NCT07630155 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Survey Administration is the first listed.

NCT07630155 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07630155 about?

NCT07630155 is a clinical study titled "Office-Based Ureteroscopy Utilizing a Single Use Digital, Flexible Ureteroscope for Upper Tract Urothelial Carcinoma". This clinical trial tests how well office based ureteroscopy utilizing a single use digital, flexible ureteroscope works for the assessment of upper tract urothelial carcinoma. Ureteroscopy is a procedure in which a thin camera called a ureteroscope is used to assess patients with a known or suspect...

What is the current status of trial NCT07630155?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-08. Estimated completion is 2027-08.

What interventions are being tested in trial NCT07630155?

The interventions under investigation include: Survey Administration (OTHER), Electronic Health Record Review (OTHER), Medical Device Usage and Evaluation (DEVICE), Analgesic Agent (DRUG), Lidocaine Topical (DRUG).

Who is sponsoring clinical trial NCT07630155?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.